Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chemcrux Enterprises is an India-based manufacturer specializing in bulk drug intermediates and specialty chemicals for the pharmaceutical industry. The company focuses on the production of high-quality intermediates used in the synthesis of active pharmaceutical ingredients (APIs), particularly for fluoroquinolone antibiotics such as ciprofloxacin and norfloxacin. Operating from its manufacturing facilities in Ankleshwar, Gujarat, Chemcrux provides custom synthesis and contract manufacturing services involving complex chemical processes like chlorination, nitration, and acetylation. The company is ISO 9001:2015 and ISO 14001:2015 certified, serving both domestic and international markets with a commitment to stringent quality standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chemcrux Enterprises.